ARTICLE | Clinical News
Dexisometheptene mucate: Completed Phase II enrollment
December 21, 2015 8:00 AM UTC
Tonix completed enrollment of over 200 patients in a double-blind, placebo-controlled, U.S. Phase II trial evaluating a single dose of 140 mg oral TNX-201 given when a tension-type headache occurs. ...